CS262591A3 - Indolonaphthyridines - Google Patents

Indolonaphthyridines

Info

Publication number
CS262591A3
CS262591A3 CS912625A CS262591A CS262591A3 CS 262591 A3 CS262591 A3 CS 262591A3 CS 912625 A CS912625 A CS 912625A CS 262591 A CS262591 A CS 262591A CS 262591 A3 CS262591 A3 CS 262591A3
Authority
CS
Czechoslovakia
Prior art keywords
indolonaphthyridines
Prior art date
Application number
CS912625A
Other languages
Czech (cs)
Inventor
Joachim Dr Nozulak
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19904027015 external-priority patent/DE4027015A1/en
Priority claimed from DE4027018A external-priority patent/DE4027018A1/en
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of CS262591A3 publication Critical patent/CS262591A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/06—Peri-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/16—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Psychiatry (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CS912625A 1990-08-27 1991-08-26 Indolonaphthyridines CS262591A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19904027015 DE4027015A1 (en) 1990-08-27 1990-08-27 NEW INDOLONAPHTHYRIDINE, THEIR PRODUCTION AND USE
DE4027018A DE4027018A1 (en) 1990-08-27 1990-08-27 New octa:hydro-indolo-naphthyridine derivs.

Publications (1)

Publication Number Publication Date
CS262591A3 true CS262591A3 (en) 1992-04-15

Family

ID=25896268

Family Applications (1)

Application Number Title Priority Date Filing Date
CS912625A CS262591A3 (en) 1990-08-27 1991-08-26 Indolonaphthyridines

Country Status (13)

Country Link
EP (1) EP0473550A1 (en)
JP (1) JPH04230685A (en)
KR (1) KR920004386A (en)
AU (1) AU646485B2 (en)
CA (1) CA2049642A1 (en)
CS (1) CS262591A3 (en)
FI (1) FI913991L (en)
HU (1) HUT61548A (en)
IE (1) IE913005A1 (en)
IL (1) IL99294A0 (en)
MX (1) MX9100811A (en)
NZ (1) NZ239547A (en)
PT (1) PT98778A (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP9601362A3 (en) * 1996-05-21 1999-04-28 Chinoin Gyogyszer Es Vegyeszet Process for producing optically active compounds
BR0116347A (en) * 2000-12-20 2004-07-06 Bristol Myers Squibb Pharma Co Substituted pyrazinoquinoxaline derivatives as serotonin receptor agonists and antagonists
ES2329553T4 (en) 2000-12-20 2010-12-07 Bristol-Myers Squibb Company PYROLOQUINOLINS AND SUBSTITUTED PYRIDOQUINOLINS AS SEROTONIN AGONISTS AND ANTAGONISTS.
AU2002336749A1 (en) 2001-09-21 2003-04-01 Pharmacia And Upjohn Company Tricyclic indole derivatives as 5-ht ligands
ES2364046T3 (en) 2002-12-19 2011-08-23 Bristol-Myers Squibb Company GAMMA-SUBSTITUTED TRICYCLIC CARBOLINES USED AS AGONISTS AND ANTAGONISTS OF SEROTONINE RECEPTORS.
WO2011044134A1 (en) 2009-10-05 2011-04-14 Albany Molecular Research, Inc. Epiminocycloalkyl(b)indole derivatives as serotonin sub-type 6 (5-ht6) modulators and uses thereof
AU2012207335A1 (en) 2011-01-19 2013-07-25 Albany Molecular Research, Inc. Benzofuro[3,2-c] pyridines and related analogs as serotonin sub-type 6 (5-HT6) modulators for the treatment of obesity, metabolic syndrome, cognition and schizophrenia
KR102244249B1 (en) * 2014-05-27 2021-04-26 삼성전자주식회사 Washing Machine
WO2018064465A1 (en) 2016-09-29 2018-04-05 The Regents Of The University Of California Compounds for increasing neural plasticity
JP7770673B2 (en) 2019-02-27 2025-11-17 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア Azepino-indoles and other heterocyclic compounds for treating brain disorders
CA3214953A1 (en) * 2021-04-13 2022-10-20 The Regents Of The University Of California Tetracyclic compounds for treating brain disorders
AU2022416279A1 (en) 2021-12-15 2024-07-25 Delix Therapeutics, Inc. Phenoxy and benzyloxy substituted psychoplastogens and uses thereof

Also Published As

Publication number Publication date
AU646485B2 (en) 1994-02-24
AU8271191A (en) 1992-03-05
FI913991A7 (en) 1992-02-28
FI913991L (en) 1992-02-28
JPH04230685A (en) 1992-08-19
NZ239547A (en) 1993-11-25
PT98778A (en) 1992-07-31
HUT61548A (en) 1993-01-28
EP0473550A1 (en) 1992-03-04
HU912693D0 (en) 1992-01-28
KR920004386A (en) 1992-03-27
FI913991A0 (en) 1991-08-23
IL99294A0 (en) 1992-07-15
CA2049642A1 (en) 1992-02-28
IE913005A1 (en) 1992-03-11
MX9100811A (en) 1992-04-01

Similar Documents

Publication Publication Date Title
DE4190756D2 (en) Mikrotom
DE69125252D1 (en) Röntgentherapie-simulatormachine
GB9116945D0 (en) Oxorapamycin
EP0440282A3 (en) Sensormatrix
AU111085S (en) Sunlounger
DE69126781D1 (en) Fabry-perot-modulator
EP0463302A3 (en) Pinchcock
DE69116171D1 (en) Photo- und biologisch-abbaubare polyethen-copolymere
DE69127252D1 (en) Linearlager
EP0465262A3 (en) Polysilethylenesiloxane
DE4092449D2 (en) Taschenfederkernmatratze
DE4191708D2 (en) Festkoerperlaser
EP0465263A3 (en) Polysilethylenesiloxane
EP0473003A3 (en) Solidformulations
AU110900S (en) Facsimilie
EP0467207A3 (en) Purinderivate
EP0458340A3 (en) Slitterscorer
EP0444458A3 (en) Pulsdopplerradar
EP0441276A3 (en) Electrophotoreceptor
EP0442511A3 (en) Allen-key
AU109294S (en) Listello
DE4092685D2 (en) Mehrkomponenten-kleb- und -werkstoffverarbeitungssystem
EP0447954A3 (en) Spray-station
EP0464900A3 (en) 2-biphenyl-carbapenems
EP0439820A3 (en) Vacuumswitch